Quipt Home Medical (QIPT) Stock

Quipt Home Medical's recurring revenue model and strong gross margins provide stability, despite recent setbacks and a 50% stock drop this year. Operational challenges, including Medicare policy changes and a cyberattack, have impacted revenue and profitability, contributing to the stock's decline. The company has a solid growth plan focused on organic expansion and acquisitions, aiming for 8%-10% growth in FY2025.

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q4 2024 Earnings Conference Call December 17, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Bill Sutherland - The Benchmark Company Julian Hung - Stifel Doug Cooper - Beacon Securities Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.

Posts Strong Adjusted EBITDA Margin‎ 1 ‎for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024

CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET).

Value investing principles from Benjamin Graham emphasize buying undervalued stocks based on arithmetic, not optimism, especially in a record high market. Quipt is significantly undervalued with a $256 million revenue run rate and a $122 million market cap. The aging U.S. population and a large undiagnosed market for sleep apnea create a strong growth potential for Quipt.

Quipt Home Medical Corp. (NASDAQ:QIPT ) Q3 2024 Results Conference Call August 15, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman, CEO Hardik Mehta - CFO Conference Call Participants Richard Close - Canaccord Genuity Justin Keywood - Stifel Stefan Quenneville - Venton Financial Operator Thank you for standing by. This is the conference operator.

Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.

CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2024, and are reported in United States dollars ("$", "dollars" and "US$") and have been rounded to the nearest hundred thousand.